Antiparkinsonian agents and depot phenothiazine.
D000328:Adult; D000367:Age Factors; D000978:Antiparkinson Agents / Q000008:administration & dosage*; D001480:Basal Ganglia Diseases / Q000139:chemically induced / Q000188:drug therapy / Q000517:prevention & control; D001590:Benztropine / Q000008:administration & dosage; D005260:Female; D005476:Fluphenazine / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D007267:Injections; D008297:Male; D008404:Massachusetts; D001523:Mental Disorders / Q000188:drug therapy*; D008875:Middle Aged; D012114:Residential Treatment; D012559:Schizophrenia / Q000188:drug therapy; D012737:Sex Factors; D013997:Time Factors; D014326:Tropanes / Q000008:administration & dosage*
D000978:Antiparkinson Agents; D014326:Tropanes; D001590:Benztropine; D005476:Fluphenazine